帕博利珠单抗对比多西他赛治疗PD-L1低表达晚期非小细胞肺癌的成本-效用分析
余炫瑶, 张少雅, 孙国君
Cost-utility analysis of pembrolizumab versus docetaxel for advanced PD-L1 low-expressing non-small cell lung cancer
YU Xuanyao, ZHANG Shaoya, SUN Guojun
中国医院药学杂志
.
2024, (11): 1328
-1332
.
DOI: 10.13286/j.1001-5213.2024.11.15
